Lived experience of older adults with type 1 diabetes using closed‐loop automated insulin delivery in a randomised trial

To explore the lived experience of older adults with type 1 diabetes using closed‐loop automated insulin delivery, an area previously receiving minimal attention.

[1]  Sybil A. McAuley,et al.  Glucose profiles of older adults with type 1 diabetes using sensor-augmented pump therapy in Australia: pre-randomisation results from the ORACL study. , 2022, The Lancet. Healthy longevity.

[2]  Janet M. Allen,et al.  Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents , 2022, Diabetes, obesity & metabolism.

[3]  Sybil A. McAuley,et al.  Hybrid closed‐loop therapy with a first‐generation system increases confidence and independence in diabetes management in youth with type 1 diabetes , 2022, Diabetic medicine : a journal of the British Diabetic Association.

[4]  S. Trawley,et al.  Closed-loop therapy in older adults with type 1 diabetes: hypoglycaemia benefits and risk stratification. , 2022, The Lancet. Healthy longevity.

[5]  R. Pratley,et al.  Closed-loop therapy in older adults with type 1 diabetes: hypoglycaemia benefits and risk stratification - Authors' reply. , 2022, The Lancet. Healthy longevity.

[6]  S. Fourlanos,et al.  Carbohydrate-counting education for older adults with type 1 diabetes starting first-generation closed-loop therapy: Observations from the ORACL trial. , 2022, Nutrition & dietetics: the journal of the Dietitians Association of Australia.

[7]  S. Garg,et al.  Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes , 2022, Diabetes technology & therapeutics.

[8]  D. Bruttomesso,et al.  Switching from predictive low glucose suspend to advanced hybrid closed loop control: effects on glucose control and patient reported outcomes. , 2022, Diabetes research and clinical practice.

[9]  Grant J. Smith,et al.  Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. , 2021, JAMA pediatrics.

[10]  M. Phillip,et al.  Lived experience of advanced hybrid closed-loop versus hybrid closed loop: patient-reported outcomes and perspectives. , 2021, Diabetes technology & therapeutics.

[11]  J. Overland,et al.  Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS/ADEA/APEG/ADIPS Working Group , 2021, The Medical journal of Australia.

[12]  K. Barnard,et al.  Cost considerations for adoption of diabetes technology are pervasive: A qualitative study of persons living with type 1 diabetes and their families , 2021, Diabetic medicine : a journal of the British Diabetic Association.

[13]  Allyson S. Hughes,et al.  “I’ve Had an Alarm Set for 3:00 a.m. for Decades”: The Impact of Type 1 Diabetes on Sleep , 2021, Clinical Diabetes.

[14]  Sybil A. McAuley,et al.  Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial , 2020, Diabetes Care.

[15]  E. Toschi,et al.  Benefits and Challenges of Diabetes Technology Use in Older Adults. , 2020, Endocrinology and metabolism clinics of North America.

[16]  A. Karter,et al.  Severe Hypoglycemia and Cognitive Function in Older Adults With Type 1 Diabetes: The Study of Longevity in Diabetes (SOLID) , 2019, Diabetes Care.

[17]  T. Kubiak,et al.  Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German/Austrian DPV registry , 2019, Diabetic medicine : a journal of the British Diabetic Association.

[18]  L. Fried,et al.  Frailty: implications for clinical practice and public health , 2019, The Lancet.

[19]  Darrell M. Wilson,et al.  One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System , 2019, Diabetes Care.

[20]  Shih-Yi Lin,et al.  Clinical guidelines for type 1 diabetes mellitus with an emphasis on older adults: an Executive Summary , 2019, Diabetic medicine : a journal of the British Diabetic Association.

[21]  Janet M. Allen,et al.  Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study , 2019, Diabetes technology & therapeutics.

[22]  V. Shah,et al.  Severe hypoglycemia is associated with high risk for falls in adults with type 1 diabetes , 2018, Archives of Osteoporosis.

[23]  L. Leach,et al.  A re‐examination of Montreal Cognitive Assessment (MoCA) cutoff scores , 2018, International journal of geriatric psychiatry.

[24]  B. Buckingham,et al.  Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users , 2020, Journal of health psychology.

[25]  B. Buckingham,et al.  Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System , 2017, The Diabetes educator.

[26]  J. E. Morley,et al.  The I.A.N.A. task force on frailty assessment of older people in clinical practice , 2008, The journal of nutrition, health & aging.

[27]  V. Braun,et al.  Using thematic analysis in psychology , 2006 .

[28]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[29]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.